Doshi Capital is investing in technology aimed at improving patient care.

The Privcap Game Change: Healthcare 2016 conference, in its second year, brought together private equity investors, institutional investors, and disrupters from the healthcare sector.

The founder of EnvisionRx and a partner at TPG discuss how they partnered to disrupt the pharmacy benefits management space

The founder of RxAdvance explains how it is trying to help pharmacy benefit managers tap the market’s full monetary potential.

Still, investors need to practice caution, says a managing director from Siguler Guff.

Healthcare is on the fast track to becoming 20 percent of U.S. GDP. Great Point Partners’ Adam Dolder says the time to invest is now.

Private equity is increasingly looking to specialized areas of healthcare such as dermatology for investments because of their resistance to reimbursement pressures, but shying away from other areas thought to be more popular.

Subsectors such as dermatology and behavioral health face less reimbursement pressures and have other opportunities for private equity

Private equity is increasingly turning its attention to consolidation plays as few doctors are specializing in the sector, say experts from LLR Partners and Riverside.

The founder and CEO of Virtus Real Estate Capital discusses how investors are responding to the changing healthcare delivery model.

Jaime Cardoso of Bozano Investimentos talks about the trends driving education and healthcare investing in a struggling Brazilian economy.

A discussion between two experts on where to invest in healthcare today

Three experts explain why healthcare is a best bet for surviving a recession.

Healthcare is one of the most rapidly evolving sectors in private capital investment as policymakers, providers, entreprenuers and consumers continue to redefine the landscape. In this Privcap conversation, experts from Comvest Partners and HealthInvest Equity Partners zero in on trends in the healthcare services sector, outlining what to expect in the near future and how…

Animal health and wellness has historically been overshadowed by human healthcare for PE investments. That’s about to change.

This briefing is a compilation of the thought leadership on display at the Healthcare Game Change event.

With commonsense data gathering, Sherpaa hopes to revolutionize consumer healthcare.

Dr. Joshua Bilenker, a practicing physician who also happens to be a venture partner at Aisling Capital, discussed his investment in Loxo Oncology, and the nexus of medicine and investment.